ERBB2 c.620A>C ;(p.E207A)

Variant ID: 17-37866111-A-C

NM_004448.2(ERBB2):c.620A>C;(p.E207A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Disruption of estrogen receptor beta's DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer.

Frontiers In Medicine
Aspros, Kirsten G M KGM; Emch, Michael J MJ; Wang, Xiyin X; Subramaniam, Malayannan M; Hinkle, Megan L ML; Rodman, Esther P B EPB; Goetz, Matthew P MP; Hawse, John R JR
Publication Date: 2023

Variant appearance in text: HER2: E207A
PubMed Link: 36926316
Variant Present in the following documents:
  • Main text
  • fmed-10-1047166.pdf
View BVdb publication page



The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane.

Frontiers In Physiology
Acconcia, Filippo F; Marino, Maria M
Publication Date: 2011

Variant appearance in text: HER-2: E207A
PubMed Link: 21747767
Variant Present in the following documents:
  • Main text
  • fphys-02-00030.pdf
View BVdb publication page